Patent US5151355A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5151355A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for the production of high purity thrombin

Assignee: Warner Lambert Pottery Road Ltd
•
Filing: 1991-01-23
•
Granted: 1992-09-29
•
Expires: 2011-01-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A liquid thrombin preparation is prepared by reacting a unit of prothrombin with less than 5 units of thromboplastin in the presence of calcium, contacting the resultant thrombin with a phosphate buffer, and diluting and filtering the suspension. The filtrate is then applied sequentially to an anion-exchange agarose column and a cation-exchange agarose column and the thrombin fraction is step-wise eluted from the latter column with phosphate buffered saline. Liquid thrombin preparations thereby obtained have specific activities greater than 1,600 U/mg and can be used in haemostasis.

Inventors

  • 👤 Carmel Crowley
  • 👤 Timothy G. Sheehan
  • 👤 Frederick G. Ward

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 09:23
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6429; A; A61; A61P; A61P7/00; A61P7/04; C12Y; C12Y304/00; C12Y304/21; C12Y304/21005

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 96 words
A process for the production of a liquid thrombin preparation, which process comprises reacting each unit of prothrombin measured as N.I.H. units of thrombin produced, with less than 5 units of thromboplastin, measured as N.I.H. units of thrombin produced, in the presence of calcium to produce thrombin contacting the resultant thrombin with a phosphate buffer to produce a suspension diluting and filtering the suspension to produce a filtrate applying the filtrate sequentially to an anion-exchange agarose column and a cation-exchange agarose column and step-wise eluting a thrombin fraction from the cation-exchange column with phosphate buffered saline.
Claim 2
Dependent Claim 96 words
A process for the production of a liquid thrombin preparation, which process comprises reacting each unit of prothrombin measured as N.I.H. units of thrombin produced, with less than 5 units of thromboplastin, measured as N.I.H. units of thrombin produced, in the presence of calcium to produce thrombin contacting the resultant thrombin with a phosphate buffer to produce a suspension diluting and filtering the suspension to produce a filtrate applying the filtrate sequentially to an anion-exchange agarose column and a cation-exchange agarose column and step-wise eluting a thrombin fraction from the cation-exchange column with phosphate buffered saline.
Claim 3
Dependent Claim 18 words
A process according to claim 1, wherein the amount of thromboplastin used is between 2 and 4 units.
Claim 4
Dependent Claim 19 words
A process according to claim 1, wherein the amount of thromboplastin used is of the order of 3 units.
Claim 5
Dependent Claim 19 words
A process according to claim 1, wherein the phosphate buffer used is a 0.5-1.5M phosphate buffer at pH 6.0-7.0.
Claim 6
Dependent Claim 19 words
A process according to claim 1, wherein the phosphate buffer used is a 1.0M phosphate buffer at pH 6.5.
Claim 7
Dependent Claim 20 words
A process according to claim 1, wherein the step-wise elution of the cation exchange agarose column is a two-step elution.
Claim 8
Dependent Claim 27 words
A process according to claim 1, wherein the cation exchange agarose column is sequentially eluted with i) 0.16-0.18M phosphate buffered saline and ii) 0.26-0.30M phosphate buffered saline.
Claim 9
Dependent Claim 27 words
A process according to claim 1, wherein the cation exchange agarose column is sequentially eluted with i) 0.17M phosphate buffered saline and ii) 0.28M phosphate buffered saline.

References Cited (Backward Citations)

DE265329C Cited
US4286056A Cited
US4363319A Cited
US4380511A Cited
US4470969A Cited
US4473553A Cited
US4736018A Cited
US4637932A Cited
US4696812A Cited
US4965203A Cited
SU1527261A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-09-29 1996-03-30 1996-09-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-09-29 2000-03-30 2000-09-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-09-29 2004-03-30 2004-09-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag